TumoralTP53and/orCDKN2Aalterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group

Biomarkers in Ewing sarcoma: the promise and challenge of personalized medicine. A report from the Children’s Oncology Group

(2014) Neerav Shukla   Frontiers in Oncology

A decade in banking Ewing sarcoma: a report from the Children’s Oncology Group

(2014) Scott Borinstein   Frontiers in Oncology

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

(2012) Richard B. Womer et al.   JOURNAL OF CLINICAL ONCOLOGY

A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893

(2012) Judy L. Felgenhauer et al.   PEDIATRIC BLOOD & CANCER

Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry

(2010) Joe Lee et al.   CANCER

Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's Sarcoma Family of Tumors

(2010) José Antonio López-Guerrero et al.   INTERNATIONAL JOURNAL OF CANCER

Biomarkers in oncology drug development

(2008) Darren R. Hodgson et al.   Molecular Oncology